Whereas CL-14 already has been described to be permissive in a preprint [47], the breast carcinoma cell line CAL-51 with high levels of NRP1 beside ACE2 and TMPRSS2 expression and the colon carcinoma cell line CL-40 have not been identified before. This evidence concerns the gene TMPRSS2 and breast carcinoma.